Eris Lifesciences Q2 Profit Rises 39% to ₹187 Crore
Eris Lifesciences reported consolidated net profit of ₹187.14 crore for the September quarter, up 39% from ₹134.47 crore a year earlier. The company cited growth in its domestic branded formulations business.
Eris Lifesciences Ltd on Monday reported a 39.16 per cent rise in consolidated net profit to ₹187.14 crore in the September quarter, driven by growth in its domestic branded formulations business.The company had posted a net profit of ₹134.47 crore in the same period of the previous fiscal year, Er…